13F-HR filed by Blue Water Life Science Advisors, LP
Blue Water Life Science Advisors, LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 8 holding rows worth $148,863,925.
- Accession
- 0001172661-23-000869
- Filer
- CIK 1789778
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 8 entries on the cover page, a total value of $148,863,925 stated on the cover page (in dollars after the unit check, H1), rows summing to $148,863,925 with VALUE read as dollars as filed, 13F file number 028-20810. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NATERA INC COM | 632307104 | Stock | 881,436 | $35,407,284 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 868,445 | $23,621,704 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 3,030,434 | $23,152,516 | dollars as filed | |
| AKOYA BIOSCIENCES INC COM | 00974H104 | Stock | 1,847,785 | $17,683,302 | dollars as filed | |
| MAXCYTE INC | 57777K106 | COM | 3,225,000 | $17,608,500 | dollars as filed | |
| CYTEK BIOSCIENCES INC | 23285D109 | COMMON STOCK | 1,300,000 | $13,273,000 | dollars as filed | |
| SONENDO INC | 835431107 | Common Stocks | 4,643,461 | $13,140,994 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 18,750 | $4,976,625 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-23-000869 | this filing | 2023-02-14 | acceptance time not in the bulk data set |